Canada markets close in 5 hours 37 minutes

PFE Jan 2024 60.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
2.0900-0.0100 (-0.48%)
As of 03:57PM EST. Market open.
Full screen
Previous Close2.1000
Open2.0900
Bid2.0600
Ask2.3800
Strike60.00
Expire Date2024-01-19
Day's Range2.0900 - 2.0900
Contract RangeN/A
Volume9
Open Interest10.56k
  • Motley Fool

    3 Reasons Pfizer Stock Will Crush the Broader Market in 2023

    Pfizer (NYSE: PFE) is a 173-year-old company with a huge portfolio of products. This year, Pfizer has dropped about 16%, in line with the S&P 500. In fact, there are three reasons Pfizer stock could crush the broader market in 2023.

  • Zacks

    Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why

    Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.

  • Business Wire

    Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

    NEW YORK, November 28, 2022--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Angela Hwang, Chief Commercial Officer, President, Global Biopharmaceuticals Business; Kevin Sullivan, Global Specialty Care & U.S. President; and Navin Katyal, U.S. Commercial and Global Business Lead for mRNA Portfolio, at the Evercore ISI HealthCONx Conference on Thursday, December 1, 2022 at 4:20 p.m. EST.